April 11 (Reuters) - Alexion Pharmaceuticals said on Wednesday it had agreed to buy Sweden’s Wilson Therapeutics for 7.1 billion Swedish crowns ($855 million) to boost its line-up of rare disease drugs.
The U.S. group is acquiring the business through a tender offer worth 232 crowns per share.
$1 = 8.3000 Swedish crowns Reporting by Ben Hirschler; Editing by Susan Fenton
